Sicart Associates LLC - VANECK VECTORS ETF TR ownership

VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 715 filers reported holding VANECK VECTORS ETF TR in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.6%.

Quarter-by-quarter ownership
Sicart Associates LLC ownership history of VANECK VECTORS ETF TR
ValueSharesWeighting
Q1 2022$232,000
-10.1%
6,055
-25.3%
0.06%
-10.4%
Q4 2021$258,000
+7.9%
8,1050.0%0.07%
+3.1%
Q3 2021$239,000
-22.7%
8,105
-11.0%
0.06%
-12.2%
Q2 2021$309,000
+19.3%
9,105
+14.5%
0.07%
+8.8%
Q1 2021$259,000
+26.3%
7,955
+51.8%
0.07%
+11.5%
Q3 2020$205,000
-1.9%
5,240
-7.9%
0.06%
-9.0%
Q2 2020$209,0005,6900.07%
Other shareholders
VANECK VECTORS ETF TR shareholders Q4 2020
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 738,500$19,873,03580.92%
New Harbor Financial Group, LLC 1,680,752$45,229,03314.96%
TORQ CAPITAL MANAGEMENT (HK) Ltd 139,000$3,740,4909.95%
Vanderbilt University 1,360,540$36,612,1319.45%
Eschler Asset Management LLP 300,000$8,073,0009.42%
New Harbor Financial Group, LLC 1,027,300$27,644,6439.15%
Guild Investment Management, Inc. 139,333$3,749,4546.28%
Monaco Asset Management SAM 750,000$20,182,5005.98%
STRATEGIC INVESTMENT MANAGEMENT, LLC 132,460$3,867,8324.74%
PCG Wealth Advisors, LLC 264,614$7,120,7824.67%
View complete list of VANECK VECTORS ETF TR shareholders